Remdesevir And COVID-19, The ACTT-1 Trial.

   

Whiteboard Doctor

 

Published on Jul 3, 2020

Whiteboard Style discussion on the randomized control trial published in the New England Journal of Medicine on Remdesevir for the treatment of COVID-19. They found decreased time to clinical improvement, but is that the end of it?

Remdesivir And COVID-19 Playlist:
https://youtube.com/playlist?list=PLf5bMa9_tvRjx3CH7XSjz4jOljuQ623tf

We have just recently debuted a Patreon page with exclusive perks, WhiteBoard Doctor merchandise, and more! Come check it out and consider becoming a WBDR Patreon!
https://www.patreon.com/WBDR

ACTT-1 Trial: https://www.nejm.org/doi/full/10.1056/NEJMoa2007764

Links to Other Videos on Remdesevir:
Compilation Of Remdesevir Videos To Date - https://www.youtube.com/watch?v=bU-3VbzEfpM&t=134s
First Remdesevir Video At Start Of Pandemic Intro To Mechanism - https://www.youtube.com/watch?v=qLXpGTY5sug
In Vitro Efficacy Of Remdesevir Against SARS-CoV-2 Virus - https://www.youtube.com/watch?v=EdRJ4BpHiNI
NEJM Compassionate Use Of Remdesevir - https://www.youtube.com/watch?v=B17DYdW4bF4

There will be a running series of videos using the most up to date information on COVID-19, but this is an evolving field and new videos may come out that contradict that previous information. That is okay and is the nature of a fast paced and evolving clinical scenario. Stick with us as we work to unveil the intricacies of COVID-19, it's clinical significance, and the societal implications. *****This is strictly educational and not to be mistaken as clinical recommendations, please verify all information with accepted guidelines and practice patterns.****


  AutoPlay Next Video